** BMO Capital Markets downgrades rating on chemical company Dow DOW.N to "underperform" from "market perform", lowers PT to $22 from $29
** New PT represents a 20.7% downside to the stock's last close
** Brokerage says weakness across its end-markets is resulting in soft pricing and lower volumes/operating rates, which will likely result in severely challenged Q2 EBITDA and 2H estimates coming solidly lower
** "With no end in sight for these anemic earnings levels, there appears a heightened risk DOW may cut the dividend," - BMO adds
** 3 of 22 brokerages rate the stock "buy" or higher, 16 "hold" and 3 "sell" or lower; median PT is $32 - data compiled by LSEG
** Up till last close, stock down 30.8% YTD
(Reporting by Pooja Menon in Bengaluru)
((Pooja.Menon@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。